Imagenebio Inc (IMA) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Imagenebio Inc (IMA) following the 2026 Q2 hedge fund 13F filings?

As of today, IMA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), IMA gained -1.0% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Imagenebio Inc (IMA)

36 + Investors. Track Smart Money conviction in IMA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — IMA

Based on 36 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds reduced or closed their IMA positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

📊

High ownership — 90% of 2.5Y peak

90% of all-time peak

36 funds currently hold this stock — 90% of the 2.5-year high of 40 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

🚀

Fast accumulation — +3500% more funds vs a year ago

fund count last 6Q

+35 new funds entered over the past year (+3500% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟡

Slight buying edge — 59% buying

22 buying15 selling

Last quarter: 22 funds bought or added vs 15 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

⚠️

Fewer new buyers each quarter (-8 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 0 → 31 → 14 → 6. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

🔄

Mostly new holders — 97% entered in last year

■ 3% conviction (2yr+) ■ 0% medium ■ 97% new

Only 1 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares +12%, value -19%

Value

-18%

+12%

Last quarter: funds added +12% more shares while total portfolio value only changed -19%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📊

Peak discovery — momentum slowing

0 → 0 → 31 → 14 → 6 new funds/Q

New funds entering each quarter: 0 → 31 → 14 → 6. IMA is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.

🌱

Early stage — 97% of holders entered in last year

■ 3% veterans ■ 0% 1-2yr ■ 97% new

Of 36 current holders: 35 (97%) entered in the past year, only 1 (3%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 8% AUM from top-100

8% from top-100 AUM funds

13 of 36 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

6.9

out of 10

Moderate Exit Risk

Exit risk score 6.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	36	40	-10.0%
13F Shares	5M	5M	12.24%
Total Value	$27M	$33M	-18.69%
New Positions	6	14	-8
Increased Positions	16	12	+4
Closed Positions	10	6	+4
Reduced Positions	5	4	+1
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

-10.0%

13F Shares

12.24%

Total Value

$27M

$33M

-18.69%

New Positions

-8

Increased Positions

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

36 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMA. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 IMA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Monashee Investment Management LLC	1.90%	192,344	$1.1M
2	Omega Fund Management, LLC	1.45%	455,361	$2.7M
3	Blue Owl Capital Holdings LP	0.81%	917,692	$5.4M
4	BML Capital Management, LLC	0.67%	200,730	$1.2M
5	Trails Edge Capital Partners, LP	0.26%	282,004	$1.7M
6	Stonepine Capital Management, LLC	0.25%	96,172	$539K
7	Nano Cap New Millennium Growth Fund L P	0.23%	50,000	$295K
8	Bvf Inc/Il	0.17%	1,110,002	$6.5M
9	Rangeley Capital, LLC	0.11%	20,090	$119K
10	Orbimed Advisors LLC	0.10%	909,269	$5.4M
11	Cable Car Capital, LP	0.10%	781,599	$4.6M
12	Aldebaran Capital, LLC	0.08%	18,124	$107K
13	NEA Management Company, LLC	0.02%	50,005	$295K
14	Rtw Investments, LP	0.02%	334,445	$2.0M
15	Sofinnova Investments, Inc.	0.01%	31,884	$188K
16	Shay Capital LLC	0.01%	18,080	$107K
17	Renaissance Technologies LLC	0.00%	86,930	$513K
18	Adage Capital Partners GP, L.L.C.	0.00%	66,666	$393K
19	Caitong International Asset Management Co., Ltd	0.00%	464	$3K
20	Tower Research Capital LLC (TRC)	0.00%	675	$4K
21	HSBC Holdings plc	0.00%	34,228	$208K
22	Two Sigma Investments, LP	0.00%	19,900	$117K
23	Vanguard Capital Management LLC	0.00%	320,518	$1.9M
24	Citadel Advisors LLC	0.00%	55,610	$328K
25	Vanguard Fiduciary Trust Co	0.00%	27,475	$162K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Imagenebio Inc (IMA)

What does the Smart Money Trend signal show for IMA?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their IMA positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for IMA?

Slight buying edge — 59% buying: Last quarter: 22 funds bought or added vs 15 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for IMA holders?

Smaller funds dominant — 8% AUM from top-100: 13 of 36 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held IMA?

Mostly new holders — 97% entered in last year: Only 1 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Imagenebio Inc (IMA) following the 2026 Q2 hedge fund 13F filings?

As of today, IMA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), IMA has gained -1.0% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Imagenebio Inc (IMA)

Smart Money Signals — IMA

Selling streak — 1 quarter in a row

High ownership — 90% of 2.5Y peak

Fast accumulation — +3500% more funds vs a year ago

Slight buying edge — 59% buying

Fewer new buyers each quarter (-8 vs last Q)

Mostly new holders — 97% entered in last year

Buying through price weakness — shares +12%, value -19%

Peak discovery — momentum slowing

Early stage — 97% of holders entered in last year

Smaller funds dominant — 8% AUM from top-100

Institutional Sentiment Summary — IMA

Hedge Fund Ownership: IMA

Market Analysis: IMA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: IMA

Is It Too Late to Buy Imagenebio Inc (IMA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: IMA

Statistics: IMA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Imagenebio Inc (IMA)

Welcome to 13Foresight!